{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T05:10:22Z","timestamp":1728882622723},"posted":{"date-parts":[[2024,8,17]]},"group-title":"In Review","reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,7,16]]},"abstract":"<title>Abstract<\/title>\n        <p>Neurodegenerative pathologies such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, Multiple sclerosis, HIV-associated neurocognitive disorder, and others significantly affect individuals, their families, caregivers, and healthcare systems. While there are no cures yet, researchers worldwide are actively working on the development of novel treatments that have the potential to slow disease progression, alleviate symptoms, and ultimately improve the overall health of patients. Huge volumes of new scientific information necessitate new analytical approaches for meaningful hypothesis generation. To enable the automatic analysis of biomedical data we introduced AGATHA, an effective AI-based literature mining tool that can navigate massive scientific literature databases, such as PubMed. The overarching goal of this effort is to adapt AGATHA for drug repurposing by revealing hidden connections between FDA-approved medications and a health condition of interest. Our tool converts the abstracts of peer-reviewed papers from PubMed into multidimensional space where each gene and health condition are represented by specific metrics. We implemented advanced statistical analysis to reveal distinct clusters of scientific terms within the virtual space created using AGATHA-calculated parameters for selected health conditions and genes. Partial Least Squares Discriminant Analysis was employed for categorizing and predicting samples (122 diseases and 20889 genes) fitted to specific classes. Advanced statistics were employed to build a discrimination model and extract lists of genes specific to each disease class. Here we focus on drugs that can be repurposed for dementia treatment as an outcome of neurodegenerative diseases. Therefore, we determined dementia-associated genes statistically highly ranked in other disease classes. Additionally, we report a mechanism for detecting genes common to multiple health conditions. These sets of genes were classified based on their presence in biological pathways, aiding in selecting candidates and biological processes that are exploitable with drug repurposing.<\/p>","DOI":"10.21203\/rs.3.rs-4750719\/v1","type":"posted-content","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T02:06:23Z","timestamp":1723860383000},"source":"Crossref","is-referenced-by-count":0,"title":["AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia"],"prefix":"10.21203","author":[{"given":"Aliaksandra","family":"Sikirzhytskaya","sequence":"first","affiliation":[{"name":"University of South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Tyagin","sequence":"additional","affiliation":[{"name":"University of Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Scott","family":"Sutton","sequence":"additional","affiliation":[{"name":"University of South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Wyatt","sequence":"additional","affiliation":[{"name":"University of South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Safro","sequence":"additional","affiliation":[{"name":"University of Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shtutman","sequence":"additional","affiliation":[{"name":"University of South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12859-023-05572-x","article-title":"A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks","volume":"24","author":"Amiri R","year":"2023","unstructured":"Amiri R, Razmara J, Parvizpour S, Izadkhah H. A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks. BMC Bioinformatics. 2023;24(1):442.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You Y","year":"2022","unstructured":"You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S, et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther. 2022;7(1):156.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"20220675","DOI":"10.1515\/biol-2022-0675","article-title":"Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development","volume":"18","author":"Chen X","year":"2023","unstructured":"Chen X, Zhang J, Zhao Q, Ding L, Wu Z, Jia Z, He D. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development. Open Life Sci. 2023;18(1):20220675.","journal-title":"Open Life Sci"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay M","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40\u201351.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom S","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41\u201358.","journal-title":"Nat Rev Drug Discov"},{"issue":"7607","key":"ref6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo N","year":"2016","unstructured":"Nosengo N. Can you teach old drugs new tricks? Nature. 2016;534(7607):314\u20136.","journal-title":"Nature"},{"year":"2017","author":"Sybrandt J","key":"ref7","unstructured":"Sybrandt J, Shtutman M, Safro I. MOLIERE: Automatic Biomedical Hypothesis Generation System. KDD: proceedings International Conference on Knowledge Discovery & Data Mining. 2017;2017:1633-42."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Sybrandt J, Tyagin I, Shtutman M, Safro I, editors. AGATHA: Automatic Graph Mining And Transformer based Hypothesis Generation Approach. Proceedings of the 29th ACM International Conference on Information & Knowledge Management; 2020.","DOI":"10.1145\/3340531.3412684"},{"issue":"7722","key":"ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/d41586-018-06617-5","article-title":"How AI technology can tame the scientific literature","volume":"561","author":"Extance A","year":"2018","unstructured":"Extance A. How AI technology can tame the scientific literature. Nature. 2018;561(7722):273\u20134.","journal-title":"Nature"},{"issue":"9","key":"ref10","article-title":"Artificial Intelligence-Based Medical Data Mining","volume":"12","author":"Zia A","year":"2022","unstructured":"Zia A, Aziz M, Popa I, Khan SA, Hamedani AF, Asif AR. Artificial Intelligence-Based Medical Data Mining. J Pers Med. 2022;12(9).","journal-title":"J Pers Med"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/bioinformatics\/btq667","article-title":"Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature","volume":"27","author":"Doughty E","year":"2011","unstructured":"Doughty E, Kertesz-Farkas A, Bodenreider O, Thompson G, Adadey A, Peterson T, Kann MG. Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature. Bioinformatics. 2011;27(3):408\u201315.","journal-title":"Bioinformatics"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13321-020-00450-7","article-title":"A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Jarada TN","year":"2020","unstructured":"Jarada TN, Rokne JG, Alhajj R. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. J Cheminform. 2020;12(1):46.","journal-title":"J Cheminform"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"114239","DOI":"10.1016\/j.ejmech.2022.114239","article-title":"Drug repositioning: Progress and challenges in drug discovery for various diseases","volume":"234","author":"Hua Y","year":"2022","unstructured":"Hua Y, Dai X, Xu Y, Xing G, Liu H, Lu T, et al. Drug repositioning: Progress and challenges in drug discovery for various diseases. Eur J Med Chem. 2022;234:114239.","journal-title":"Eur J Med Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"112732","DOI":"10.1016\/j.psychres.2019.112732","article-title":"Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review","volume":"284","author":"Graham SA","year":"2020","unstructured":"Graham SA, Lee EE, Jeste DV, Van Patten R, Twamley EW, Nebeker C, et al. Artificial intelligence approaches to predicting and detecting cognitive decline in older adults: A conceptual review. Psychiatry Res. 2020;284:112732.","journal-title":"Psychiatry Res"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1038\/s41467-022-33397-4","article-title":"Deciphering microbial gene function using natural language processing","volume":"13","author":"Miller D","year":"2022","unstructured":"Miller D, Stern A, Burstein D. Deciphering microbial gene function using natural language processing. Nat Commun. 2022;13(1):5731.","journal-title":"Nat Commun"},{"issue":"7612","key":"ref16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nj7612-457a","article-title":"Scientific literature: Information overload","volume":"535","author":"Landhuis E","year":"2016","unstructured":"Landhuis E. Scientific literature: Information overload. Nature. 2016;535(7612):457\u20138.","journal-title":"Nature"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cem.785","article-title":"Partial Least Squares for Discrimination","volume":"17","author":"Matthew Barker WR","year":"2003","unstructured":"Matthew Barker WR. Partial Least Squares for Discrimination. Journal of Chemometrics. 2003;17(3):166\u201373.","journal-title":"Journal of Chemometrics"},{"issue":"15","key":"ref18","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1039\/C8AN00599K","article-title":"Partial least squares-discriminant analysis (PLS-DA) for classification of high-dimensional (HD) data: a review of contemporary practice strategies and knowledge gaps","volume":"143","author":"Lee LC","year":"2018","unstructured":"Lee LC, Liong CY, Jemain AA. Partial least squares-discriminant analysis (PLS-DA) for classification of high-dimensional (HD) data: a review of contemporary practice strategies and knowledge gaps. Analyst. 2018;143(15):3526\u201339.","journal-title":"Analyst"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00216-019-01786-2","article-title":"Chemometrics: data driven extraction for science","volume":"411","author":"Bocklitz T","year":"2019","unstructured":"Bocklitz T. Richard G. Brereton: Chemometrics: data driven extraction for science, 2nd ed. Anal Bioanal Chem. 2019;411(14):2995\u20136.","journal-title":"Anal Bioanal Chem"},{"issue":"198","key":"ref20","doi-asserted-by":"crossref","first-page":"20220406","DOI":"10.1098\/rsif.2022.0406","article-title":"Neurodegenerative disease of the brain: a survey of interdisciplinary approaches","volume":"20","author":"Davenport F","year":"2023","unstructured":"Davenport F, Gallacher J, Kourtzi Z, Koychev I, Matthews PM, Oxtoby NP, et al. Neurodegenerative disease of the brain: a survey of interdisciplinary approaches. J R Soc Interface. 2023;20(198):20220406.","journal-title":"J R Soc Interface"},{"key":"ref21","unstructured":"WHO. The top 10 causes of death 2020 [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann GM","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"W1","key":"ref23","doi-asserted-by":"crossref","first-page":"W207-W12","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg L","year":"2023","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, Peterson H. g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 2023;51(W1):W207-W12.","journal-title":"Nucleic Acids Res"},{"issue":"1 30","key":"ref24","first-page":"1","article-title":"The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses","volume":"54","author":"Stelzer G","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016;54:1 30 1\u20131 3.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"Database issue","key":"ref25","first-page":"D1104-14","article-title":"The Comparative Toxicogenomics Database: update 2013","volume":"41","author":"Davis AP","year":"2013","unstructured":"Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, Saraceni-Richards C, et al. The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res. 2013;41(Database issue):D1104-14.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/h0071325","article-title":"Analysis of a complex of statistical variables into principal components","volume":"24","author":"Hotelling H","year":"1933","unstructured":"Hotelling H. Analysis of a complex of statistical variables into principal components. Journal of Educational Psychology. 1933;24(6):417\u201341.","journal-title":"Journal of Educational Psychology"},{"issue":"301","key":"ref27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","volume":"58","author":"Hierarchical Grouping to Optimize an Objective Function","year":"1963","unstructured":"Hierarchical Grouping to Optimize an Objective Function. Journal of the American Statistical Association. 1963;58(301):236\u201344.","journal-title":"Journal of the American Statistical Association"},{"issue":"5","key":"ref28","first-page":"40","article-title":"The Unified Medical Language System (UMLS) of the National Library of Medicine","volume":"61","author":"Lindberg C","year":"1990","unstructured":"Lindberg C. The Unified Medical Language System (UMLS) of the National Library of Medicine. J Am Med Rec Assoc. 1990;61(5):40\u20132.","journal-title":"J Am Med Rec Assoc"},{"author":"System UML","key":"ref29","unstructured":"System UML. Diseases Database Source Information U.S. National Library of Medicine2010 [Available from: https:\/\/www.nlm.nih.gov\/research\/umls\/sourcereleasedocs\/current\/DDB\/index.html."},{"issue":"6569","key":"ref30","doi-asserted-by":"crossref","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","article-title":"Mapping the proteo-genomic convergence of human diseases","volume":"374","author":"Pietzner M","year":"2021","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, Worheide MA, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374(6569):eabj1541.","journal-title":"Science"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000943","article-title":"Literature mining for the discovery of hidden connections between drugs, genes and diseases","volume":"6","author":"Frijters R","year":"2010","unstructured":"Frijters R, van Vugt M, Smeets R, van Schaik R, de Vlieg J, Alkema W. Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput Biol. 2010;6(9).","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"e67-e492","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association","volume":"137","author":"Benjamin EJ","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67-e492.","journal-title":"Circulation"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41467-022-29539-3","article-title":"Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy","volume":"13","author":"Kim ST","year":"2022","unstructured":"Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, et al. Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nat Commun. 2022;13(1):1970.","journal-title":"Nat Commun"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41568-022-00518-6","article-title":"Leveraging the replication stress response to optimize cancer therapy","volume":"23","author":"Cybulla E","year":"2023","unstructured":"Cybulla E, Vindigni A. Leveraging the replication stress response to optimize cancer therapy. Nat Rev Cancer. 2023;23(1):6\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"7970","key":"ref35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-023-06179-1","article-title":"Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor","volume":"619","author":"Greenhough LA","year":"2023","unstructured":"Greenhough LA, Liang CC, Belan O, Kunzelmann S, Maslen S, Rodrigo-Brenni MC, et al. Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor. Nature. 2023;619(7970):650\u20137.","journal-title":"Nature"},{"issue":"Database issue","key":"ref36","first-page":"D668-72","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart DS","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(Database issue):D668-72.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00109-018-1673-2","article-title":"Cardiac-specific knockout and pharmacological inhibition of Endothelin receptor type B lead to cardiac resistance to extreme hypoxia","volume":"96","author":"Stobdan T","year":"2018","unstructured":"Stobdan T, Zhou D, Williams AT, Cabrales P, Haddad GG. Cardiac-specific knockout and pharmacological inhibition of Endothelin receptor type B lead to cardiac resistance to extreme hypoxia. J Mol Med (Berl). 2018;96(9):975\u201382.","journal-title":"J Mol Med (Berl)"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1124\/mol.64.6.1283","article-title":"Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells","volume":"64","author":"Eaton JB","year":"2003","unstructured":"Eaton JB, Peng JH, Schroeder KM, George AA, Fryer JD, Krishnan C, et al. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells. Mol Pharmacol. 2003;64(6):1283\u201394.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/npp.2014.240","article-title":"Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability","volume":"40","author":"Kasparbauer AM","year":"2015","unstructured":"Kasparbauer AM, Rujescu D, Riedel M, Pogarell O, Costa A, Meindl T, et al. Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability. Neuropsychopharmacology. 2015;40(3):736\u201345.","journal-title":"Neuropsychopharmacology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"849793","DOI":"10.3389\/fonc.2022.849793","article-title":"Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy","volume":"12","author":"Tilsed CM","year":"2022","unstructured":"Tilsed CM, Casey TH, de Jong E, Bosco A, Zemek RM, Salmons J, et al. Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy. Front Oncol. 2022;12:849793.","journal-title":"Front Oncol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1478-811X-11-30","article-title":"Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells","volume":"11","author":"Halbach S","year":"2013","unstructured":"Halbach S, Rigbolt KT, Wohrle FU, Diedrich B, Gretzmeier C, Brummer T, Dengjel J. Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal. 2013;11(1):30.","journal-title":"Cell Commun Signal"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-4-10","article-title":"Hydralazine target: from blood vessels to the epigenome","volume":"4","author":"Arce C","year":"2006","unstructured":"Arce C, Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Candelaria M, Duennas-Gonzalez A. Hydralazine target: from blood vessels to the epigenome. J Transl Med. 2006;4:10.","journal-title":"J Transl Med"},{"year":"2020","author":"Ji Z","key":"ref43","unstructured":"Ji Z, Wei Q, Xu H. BERT-based Ranking for Biomedical Entity Normalization. AMIA Jt Summits Transl Sci Proc. 2020;2020:269\u2009\u2013\u200977."},{"issue":"Suppl 8","key":"ref44","first-page":"S5","article-title":"Cross-species gene normalization by species inference","volume":"12","author":"Wei CH","year":"2011","unstructured":"Wei CH, Kao HY. Cross-species gene normalization by species inference. BMC Bioinformatics. 2011;12 Suppl 8(Suppl 8):S5.","journal-title":"BMC Bioinformatics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 2020;6:14.","journal-title":"Cell Discov"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"e1008686","DOI":"10.1371\/journal.pcbi.1008686","article-title":"SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19","volume":"17","author":"Fiscon G","year":"2021","unstructured":"Fiscon G, Conte F, Farina L, Paci P. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLoS Comput Biol. 2021;17(2):e1008686.","journal-title":"PLoS Comput Biol"},{"year":"2018","author":"Sybrandt J","key":"ref47","unstructured":"Sybrandt J, Shtutman M, Safro I. Large-Scale Validation of Hypothesis Generation Systems via Candidate Ranking. 2018 IEEE International Conference on Big Data (Big Data). 2018:1494\u2009\u2013\u2009503."},{"key":"ref48","article-title":"Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation","author":"Aksenova M","year":"2019","unstructured":"Aksenova M, Sybrandt J, Cui B, Sikirzhytski V, Ji H, Odhiambo D, et al. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation. J Neuroimmune Pharmacol. 2019.","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2020.09.005","article-title":"Glutamate receptors and metaplasticity in addiction","volume":"56","author":"Chiamulera C","year":"2021","unstructured":"Chiamulera C, Piva A, Abraham WC. Glutamate receptors and metaplasticity in addiction. Curr Opin Pharmacol. 2021;56:39\u201345.","journal-title":"Curr Opin Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4615-4709-9_33","article-title":"Tryptophan metabolism in alcoholism","volume":"467","author":"Badawy AA","year":"1999","unstructured":"Badawy AA. Tryptophan metabolism in alcoholism. Adv Exp Med Biol. 1999;467:265\u201374.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"ref51","first-page":"969","article-title":"The effect of tryptophan depletion on alcohol self-administration in non-treatment-seeking alcoholic individuals","volume":"26","author":"Petrakis IL","year":"2002","unstructured":"Petrakis IL, Buonopane A, O'Malley S, Cermik O, Trevisan L, Boutros NN, et al. The effect of tryptophan depletion on alcohol self-administration in non-treatment-seeking alcoholic individuals. Alcohol Clin Exp Res. 2002;26(7):969\u201375.","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/acer.14920","article-title":"Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation","volume":"46","author":"Mechtcheriakov S","year":"2022","unstructured":"Mechtcheriakov S, Gleissenthall GV, Geisler S, Arnhard K, Oberacher H, Schurr T, et al. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation. Alcohol Clin Exp Res. 2022;46(9):1648\u201356.","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13020292","article-title":"The Role of Tryptophan Metabolism in Alzheimer's Disease","volume":"13","author":"Savonije K","year":"2023","unstructured":"Savonije K, Weaver DF. The Role of Tryptophan Metabolism in Alzheimer's Disease. Brain Sci. 2023;13(2).","journal-title":"Brain Sci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4750719\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4750719\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:54:44Z","timestamp":1728881684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4750719\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":53,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4750719\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,8,17]]},"subtype":"preprint"}}